Cardiovascular Competitors

Delisted . USA . 
Stock . Cardiovascular Systems
CSIIDelisted Stock  USD 20.00  0.00  0.00%   
Cardiovascular Systems competes with Orthofix Medical, Glaukos Corp, Bruker, MaxCyte, and Sight Sciences; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Cardiovascular Systems competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Cardiovascular Systems to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Cardiovascular Systems competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
20.0020.0020.00
Details
Intrinsic
Valuation
LowRealHigh
15.5815.5822.00
Details
Naive
Forecast
LowNextHigh
20.2120.2120.21
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
19.9619.9820.01
Details

Cardiovascular Systems Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Cardiovascular Systems and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Cardiovascular and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Cardiovascular Systems does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
RPID
+ 0.9
CVRX
SGHT
+ 0.88
BRKR
SGHT
+ 0.86
MXCT
CVRX
+ 0.85
GKOS
CVRX
+ 0.84
OFIX
GKOS
+ 0.82
OFIX
  
High negative correlations   
CVRX
- 0.86
SGHT
RPID
- 0.83
SGHT
SGHT
- 0.82
GKOS
BRKR
- 0.74
GKOS
RPID
- 0.73
BRKR
CVRX
- 0.73
BRKR

Risk-Adjusted Indicators

There is a big difference between Cardiovascular Stock performing well and Cardiovascular Systems Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cardiovascular Systems' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
OFIX  1.86  0.03  0.04  0.15  2.06 
(2.07)
 3.90 
(3.85)
 12.11 
NUVA  1.23 (0.03) 0.00 (2.18) 0.00 
 0.00 
 3.31 
(2.75)
 7.19 
GKOS  1.59 (0.10)(0.01) 0.07  1.71 
(1.75)
 3.30 
(2.86)
 13.23 
HSKA  1.18  0.58  0.81  3.73  0.00 
(1.25)
 3.63 
(0.71)
 21.36 
BRKR  2.03 (0.25) 0.00 (0.15) 0.00 
 0.00 
 4.74 
(3.68)
 12.99 
MXCT  2.48 (0.40) 0.00 (0.16) 0.00 
 0.00 
 4.86 
(5.75)
 17.97 
SGHT  3.00 (1.14) 0.00 (0.22) 0.00 
 0.00 
 6.65 
(7.84)
 18.22 
CVRX  3.84  0.75  0.16  1.49  3.48 
(4.66)
 10.68 
(8.22)
 41.08 
NPCE  3.44  0.30  0.13  0.26  3.01 
(4.11)
 9.73 
(6.19)
 35.38 
RPID  2.32  0.22  0.08  0.31  2.66 
(2.79)
 5.88 
(4.55)
 24.78 
All Fundamental Data

Cardiovascular Systems Competitive Analysis

The better you understand Cardiovascular Systems competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Cardiovascular Systems' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Cardiovascular Systems' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CSII OFIX NUVA GKOS HSKA BRKR MXCT SGHT CVRX NPCE
 0.00 
 20.00 
Cardiovascular
 2.09 
 19.53 
Orthofix
 1.97 
 42.35 
NuVasive
 0.67 
 143.65 
Glaukos
 0.00 
 119.99 
Heska
 0.74 
 57.95 
Bruker
 0.85 
 3.55 
MaxCyte
 2.05 
 3.99 
Sight
 0.07 
 15.32 
CVRx
 3.41 
 10.60 
Neuropace
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Very steady
Very steady
Very steady
Very steady
Slightly risky
Relatively risky
Somewhat reliable
Moderately volatile
Market Performance
(90 Days Performance)
Very Weak
OK
Very Weak
Modest
Very Weak
Very Weak
Very Weak
Very Weak
Good
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Low
Dangerous
Low
Dangerous
Very Small
Low
Above Average
About Average
Quite High
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Not Available
Strong Buy
Not Available
Strong Buy
Strong Buy
Buy
Strong Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Not Rated
Strong Sell
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
6.05
3.15
1.17
6.78
6.92
2.55
14.24
16.73
16.82
9.86
Net Asset
322.68 M
925.32 M
2.22 B
940.41 M
585.82 M
4.25 B
268.27 M
166.65 M
115.23 M
107.65 M
Profit Margin
-0.16
-0.15
0.0232
-0.42
-0.0786
0.0941
-0.78
-0.63
-1.24
-0.37
EBITDA
(29.96 M)
(79.45 M)
211.8 M
(82.12 M)
(20.3 M)
599 M
(44.13 M)
(49.41 M)
(43.1 M)
(22.83 M)
Operating Margin
-0.16
-0.0861
0.0673
-0.26
-0.094
0.1
-1.72
-0.56
-0.97
-0.2
Current Valuation
466.13 M
853.5 M
2.91 B
7.82 B
652.94 M
11.05 B
232.21 M
117.81 M
322 M
333.06 M
Price To Book
2.43
1.42
2.62
11.85
1.74
4.86
1.76
2.12
5.7
32.21
Retained Earnings
(320 M)
(150.14 M)
86.11 M
(599.07 M)
(168.53 M)
2.32 B
(175.8 M)
(294.79 M)
(477.38 M)
(503.81 M)
Current Asset
104.88 M
147.87 M
702.83 M
104.14 M
41.26 M
1.23 B
N/A
N/A
N/A
N/A
Five Year Return
N/A
N/A
N/A
N/A
N/A
0.36
N/A
N/A
N/A
N/A
Beta
0.74
1.05
1.07
1.03
1.6
1.2
1.16
2.73
1.11
1.8
Number Of Employees
725
1.63 K
3 K
907
808
9.71 K
143
214
200
184
Shares Outstanding
42.2 M
38.21 M
52.45 M
55.14 M
10.91 M
151.6 M
105.48 M
50.4 M
24.26 M
29.85 M
Cash Flow From Operations
(24.27 M)
(45.75 M)
169.12 M
(57.76 M)
(21.81 M)
350.1 M
(21.69 M)
(47.18 M)
(39.02 M)
(19.7 M)
Annual Yield
N/A
N/A
N/A
N/A
N/A
0.0035
N/A
N/A
N/A
N/A
Total Debt
22.15 M
134.2 M
1.01 B
383.74 M
95.6 M
1.38 B
18.74 M
35.41 M
30.61 M
72.39 M
Return On Equity
-0.15
-0.21
0.0331
-0.26
-0.0473
0.2
-0.16
-0.45
-0.79
-2.15
Z Score
22.8
N/A
2.23
N/A
8.6
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.0756
-0.0237
0.0242
-0.0774
-0.0251
0.0483
-0.11
-0.19
-0.31
-0.15
Number Of Shares Shorted
1.74 M
1.66 M
5.76 M
2.81 M
1.32 M
3.01 M
3.32 M
977.46 K
2.06 M
290.4 K
Book Value Per Share
5.7
13.76
17.02
12.13
38.26
11.92
2.03
1.88
2.69
0.33
Current Liabilities
35.5 M
52.94 M
99.62 M
20.36 M
18.8 M
554.6 M
N/A
N/A
N/A
N/A
Total Asset
322.68 M
925.32 M
2.22 B
940.41 M
585.82 M
4.25 B
268.27 M
166.65 M
115.23 M
107.65 M
Debt To Equity
0.088
0.078
1.22
0.68
0.26
1.2
0.056
0.18
0.003
1.08
Short Ratio
2.66
5.43
10.29
4.97
5.41
2.04
6.72
4.06
4.46
2.7
Target Price
16.75
24.4
44.0
142.42
130.0
74.74
9.25
5.66
16.5
15.33
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
0.2
N/A
N/A
N/A
N/A
Shares Owned By Institutions
89.64
92.32
99.73
96.81
87.54
79.71
70.57
51.0
71.9
82.89
Market Capitalization
843.96 M
746.32 M
2.08 B
7.92 B
1.31 B
8.79 B
374.46 M
201.09 M
371.72 M
316.39 M
Price To Earning
724.24
338.0
51.79
94.7
498.39
67.1
N/A
N/A
0.19
N/A
Price To Earnings To Growth
177.27
0.33
4.83
1.64
2.53
3.64
N/A
N/A
N/A
N/A
Price To Sales
2.51
0.95
1.79
21.98
2.6
2.71
8.21
2.53
7.87
4.14
Net Income
(36.93 M)
(151.4 M)
40.41 M
(134.66 M)
(19.89 M)
427.2 M
(37.92 M)
(55.55 M)
(41.2 M)
(32.96 M)
Earnings Per Share
-0.96
-3.14
0.53
-2.93
-1.92
2.07
-0.34
-1.01
-2.69
-0.98
Shares Owned By Insiders
3.22
4.99
0.27
3.19
6.45
31.91
1.49
20.4
4.39
4.1
Revenue
236.22 M
746.64 M
1.2 B
314.71 M
257.31 M
2.96 B
41.29 M
81.06 M
39.3 M
65.42 M
Working Capital
69.38 M
255.22 M
149.16 M
321.45 M
225.46 M
962.1 M
172.34 M
150.62 M
104.23 M
76.49 M
Cash And Equivalents
159.83 M
59.54 M
225.98 M
391.19 M
171.93 M
733.6 M
240.89 M
220.1 M
109.98 M
92.41 M
Cash Per Share
3.9
2.98
4.34
8.22
15.89
4.95
2.37
4.6
5.34
3.72
Gross Profit
172.78 M
337.17 M
865.43 M
213.88 M
111.17 M
1.31 B
39.16 M
58.97 M
17.47 M
32.49 M
Day Typical Price
20.0
19.4
42.64
143.41
119.99
58.09
3.54
4.0
15.15
10.58
Accumulation Distribution
N/A
0.0195
0.0252
0.0157
N/A
0.0148
0.0442
0.0368
0.0454
0.028
Market Facilitation Index
N/A
0.38
1.09
2.27
N/A
0.87
0.16
0.15
0.7
0.3
Daily Balance Of Power
0.0
1.052632
(0.78)
0.4229
0.0
(0.49)
0.1875
0.5333
0.0143
1.166667
Period Momentum Indicator
N/A
0.4
(0.85)
0.96
N/A
(0.43)
0.03
0.08
0.01
0.35
Rate Of Daily Change
1.0
1.02
0.98
1.01
1.0
0.99
1.01
1.02
1.0
1.03
Day Median Price
20.0
19.34
42.79
143.29
119.99
58.17
3.54
4.01
15.06
10.57
Price Action Indicator
N/A
0.39
(0.86)
0.85
N/A
(0.43)
0.025
0.025
0.26
0.2
Relative Strength Index
73.27
86.64
46.04
66.59
47.53
37.44
45.2
39.07
84.01
59.3
Coefficient Of Variation
830.74
1101.92
(9,695)
1996.35
452.21
(2,186)
(1,533)
(565.08)
735.91
867.7
Mean Deviation
1.64
1.86
1.23
1.59
1.18
2.03
2.48
3.0
3.84
3.44
Jensen Alpha
0.6511
0.0348
(0.03)
(0.1)
0.576
(0.25)
(0.40)
(1.14)
0.7482
0.3049
Total Risk Alpha
(0.29)
(0.19)
(0.30)
(0.28)
0.1386
(0.58)
(0.77)
(1.38)
(0.20)
(0.28)
Sortino Ratio
0.3404
0.036
N/A
(0.01)
0.8107
N/A
N/A
N/A
0.1597
0.1343
Downside Variance
3.04
4.75
N/A
3.41
0.3343
N/A
N/A
N/A
18.71
12.49
Standard Deviation
6.07
2.38
1.65
2.3
2.74
2.7
3.29
4.0
6.1
5.31
Kurtosis
60.85
0.543
0.7279
4.85
44.83
2.85
0.798
0.4017
8.93
10.24
Potential Upside
1.79
3.9
3.31
3.3
3.63
4.74
4.86
6.65
10.68
9.73
Treynor Ratio
1.31
0.1536
(2.18)
0.0656
3.73
(0.15)
(0.16)
(0.22)
1.49
0.2585
Maximum Drawdown
49.04
12.11
7.19
13.23
21.36
12.99
17.97
18.22
41.08
35.38
Variance
36.89
5.67
2.73
5.3
7.52
7.29
10.83
15.97
37.17
28.22
Market Risk Adjusted Performance
1.32
0.1636
(2.17)
0.0756
3.74
(0.14)
(0.15)
(0.21)
1.5
0.2685
Risk Adjusted Performance
0.1008
0.0762
(0)
0.045
0.1763
(0.03)
(0.04)
(0.13)
0.1126
0.0967
Skewness
7.62
0.2472
0.4787
1.48
6.25
1.12
(0.53)
(0.06)
2.13
2.39
Semi Deviation
0.5837
2.06
N/A
1.71
0.0
N/A
N/A
N/A
3.48
3.01
Information Ratio
0.0977
0.0329
(0.09)
(0.01)
0.171
(0.1)
(0.11)
(0.21)
0.1133
0.0893
Value At Risk
(0.66)
(3.85)
(2.75)
(2.86)
(0.71)
(3.68)
(5.75)
(7.84)
(8.22)
(6.19)
Expected Short fall
(2.12)
(2.07)
N/A
(1.75)
(1.25)
N/A
N/A
N/A
(4.66)
(4.11)
Downside Deviation
1.74
2.18
N/A
1.85
0.5782
N/A
N/A
N/A
4.32
3.53
Semi Variance
0.3407
4.24
N/A
2.91
(0.46)
N/A
N/A
N/A
12.11
9.08

Cardiovascular Systems Competition Performance Charts

Five steps to successful analysis of Cardiovascular Systems Competition

Cardiovascular Systems' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Cardiovascular Systems in relation to its competition. Cardiovascular Systems' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Cardiovascular Systems in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Cardiovascular Systems' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Cardiovascular Systems, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Cardiovascular Systems position

In addition to having Cardiovascular Systems in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Driverless Cars Thematic Idea Now

Driverless Cars
Driverless Cars Theme
It encompasses large technology companies, automotive makers, security firms, and thematic ETFs across multiple industries. These entities are directly or indirectly involved in shaping the development and marketing of self-driving vehicles. The Driverless Cars theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Driverless Cars Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Consideration for investing in Cardiovascular Stock

If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY